< Back to previous page


Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial

Journal Contribution - Journal Article

Granulocyte colony-stimulating factor (G-CSF; AX200; Filgrastim) is a stroke drug candidate with excellent preclinical evidence for efficacy. A previous phase IIa dose-escalation study suggested potential efficacy in humans. The present large phase IIb trial was powered to detect clinical efficacy in acute ischemic stroke patients.
Journal: STROKE
ISSN: 0039-2499
Issue: 10
Volume: 44
Pages: 2681 - 7
Publication year:2013
BOF-publication weight:6
CSS-citation score:3
Authors from:Government, Higher Education